Saint-Gobain Life Sciences has launched Sani-Tech® STHT®-80 silicone tubing, designed for high burst pressure and vacuum applications. This tubing offers superior pressure resistance, eliminating the need for costly braid reinforcements, and maintains integrity under vacuum conditions. It also minimizes pulsation, improving the accuracy and efficiency of filling operations, and its high transparency allows for real-time process monitoring.
SOLON, Ohio, Sept. 25, 2024 /PRNewswire-PRWeb/ -- Saint-Gobain Life Sciences is excited to announce the launch of our latest innovation, Sani-Tech® STHT®-80 silicone tubing. Engineered with unmatched pressure resistance and vacuum compatibility, STHT-80 eliminates the need for costly braid reinforcements while ensuring uninterrupted operations, even under challenging conditions. Its superior performance translates to enhanced process capabilities, reduced costs, and improved efficiency.
Sani-Tech® STHT®-80 offers key advantages over other fluid transfer tubing, including:
- Unmatched pressure resistance: With a higher burst pressure than typical fluid transfer tubing, STHT-80 eliminates the need for costly braid reinforcements, providing a more cost-effective solution.
- Vacuum compatibility: STHT-80 maintains its integrity even under vacuum conditions, ensuring uninterrupted operations and reliability.
- Minimized pulsation: By minimizing pulsation downstream of pumping, STHT-80 improves the accuracy and efficiency of filling operations.
- High transparency: The prominent level of transparency in STHT-80 allows for real-time insights into bioprocessing workflows, enhancing monitoring and control.
"This new product launch demonstrates Saint-Gobain Life Sciences' commitment to innovation and offering best-in-class fluid transfer products, says Aaron Updegrove, Managing Director, BPS Fluid Transfer Technologies. With its superior pressure resistance, flow rates, and vacuum compatibility, STHT-80 streamlines processes and boosts cost-efficiency. We're confident that STHT-80 will empower our customers to achieve unprecedented levels of performance and efficiency."
Saint-Gobain Life Sciences' expertise in material science and deep understanding of bioprocessing needs are embodied in Sani-Tech® STHT®-80, as it is engineered to exceed expectations. The superior burst pressure resistance and vacuum compatibility of STHT-80 ensure reliable and uninterrupted operations. Additionally, the reduced pulsation leads to improved accuracy and efficiency, further demonstrating its reliability. STHT-80 adheres to relevant industry standards, providing the assurance needed for critical applications. We invite you to download the validation package to explore the comprehensive regulatory support we offer.
For more information about Sani-Tech® STHT®-80 and to download the validation package, please visit our website or contact our sales team.
About Saint-Gobain Life Sciences
Saint-Gobain Life Sciences designs and manufactures high-performance components and innovative solutions across a wide range of industries, including biopharmaceuticals, medical, electronics, food and beverage, and more. Supported by deep material expertise and a global manufacturing footprint, our focus on quality and compliance makes us a trusted partner for consistent, reliable, and sustainable solutions.
About Saint-Gobain
Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group's commitment is guided by its purpose, "MAKING THE WORLD A BETTER HOME".
€47.9 billion in sales in 2023
160,000 employees, locations in 76 countries
Committed to achieving net zero carbon emissions by 2050
Media Contact
Katy Oroszi, Saint-Gobain Life Sciences, 1 (330) 283-3536, [email protected], www.biopharm.saint-gobain.com
SOURCE Saint-Gobain Life Sciences
Share this article